A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection

Journal of Controlled Release

Volumn 131, Issue 2, 2008, Pages 113-120

  Ishii, Yumiko ^a   Nakae, Tomoko ^b   Sakamoto, Fumiko ^b   Matsuo, Kazuhiko ^a   Matsuo, Keisuke ^a   Quan, Ying Shu ^b,c   Kamiyama, Fumio ^c   Fujita, Takuya ^b,d   Yamamoto, Akira ^b   Nakagawa, Shinsaku ^a   Okada, Naoki ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c CosMED Pharmaceuticals Co Ltd ^*  (Japan)

^d RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

Adenovirus; Langerhans cell; Skin; Tetanus; Vaccine

Indexed keywords

COLLOIDS; DEVELOPING COUNTRIES; HYDROGELS; IMMUNIZATION; PROTEINS; SILVER; WEIGHT CONTROL;

ADENOVIRAL INFECTION; ADENOVIRUS; BACTERIAL INFECTIONS; GLOBAL DISTRIBUTIONS; HISTOCHEMICAL ANALYSIS; HUMORAL IMMUNITY; HYDROGEL; INFECTIOUS DISEASES; LANGERHANS CELL; LANGERHANS CELLS; LYMPH NODES; SKIN; STRATUM CORNEUM; TETANUS; TETANUS TOXIN; TRANSCUTANEOUS; VACCINE;

HEALTH;

ACRYLIC CEMENT; GLYCEROL; HYALURONIC ACID; IMMUNOGLOBULIN G; LACTIC ACID; OCTYLDODECYL LACTATE; TETANUS TOXIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFICACY; EAR CARTILAGE; FEMALE; HISTOCHEMISTRY; HUMORAL IMMUNITY; HYDROGEL; IMMUNOFLUORESCENCE; LANGERHANS CELL; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRATUM CORNEUM; VACCINATION; VIRUS INFECTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODY FORMATION; ANTIGENS, VIRAL; BACTERIAL INFECTIONS; CAPSID PROTEINS; CELL LINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYDROGEL; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; RATS; RATS, HAIRLESS; SKIN ABSORPTION; TETANUS TOXOID; VACCINATION; VACCINES; VIRUS DISEASES;

EID: 53049110285     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.07.025     Document Type: Article

References (36)

1. Hui E.K. Reasons for the increase in emerging and re-emerging viral infectious diseases. Microbes Infect. 8 3 (2006) 905-916
2. Wong G.W., and Leung T.F. Bird flu: lessons from SARS. Paediatr. Respir. Rev. 8 2 (2007) 171-176
3. Valadas E., and Antunes F. Tuberculosis, a re-emergent disease. Eur. J. Radiol. 55 2 (2005) 154-157
4. Campbell C.C. Malaria: an emerging and re-emerging global plague. FEMS Immunol. Med. Microbiol. 18 4 (1997) 325-331
5. Giudice E.L., and Campbell J.D. Needle-free vaccine delivery. Adv. Drug Deliv. Rev. 58 1 (2006) 68-89
6. Valladeau J., and Saeland S. Cutaneous dendritic cells. Semin. Immunol. 17 4 (2005) 273-283
7. Mitsui H., Watanabe T., Saeki H., Mori K., Fujita H., Tada Y., Asahina A., Nakamura K., and Tamaki K. Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J. Invest. Dermatol. 122 1 (2004) 95-102
8. Barry B.W. Breaching the skin's barrier to drugs. Nat. Biotechnol. 22 2 (2004) 165-167
9. Henry S., McAllister D.V., Allen M.G., and Prausnitz M.R. Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 87 8 (1998) 922-925
10. Lin W., Cormier M., Samiee A., Griffin A., Johnson B., Teng C.L., Hardee G.E., and Daddona P.E. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm. Res. 18 12 (2001) 1789-1793
11. Matriano J.A., Cormier M., Johnson J., Young W.A., Buttery M., Nyam K., and Daddona P.E. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm. Res. 19 1 (2002) 63-70
12. Chabri F., Bouris K., Jones T., Barrow D., Hann A., Allender C., Brain K., and Birchall J. Microfabricated silicon microneedles for nonviral cutaneous gene delivery. Br. J. Dermatol. 150 5 (2004) 869-877
13. Prausnitz M.R. Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev. 56 5 (2004) 581-587
14. Wang Y., Thakur R., Fan Q., and Michniak B. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. Eur. J. Pharm. Biopharm. 60 2 (2005) 179-191
15. Batheja P., Thakur R., and Michniak B. Transdermal iontophoresis. Expert Opin. Drug Deliv. 3 1 (2006) 127-138
16. Mizuguchi H., and Kay M.A. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum. Gene Ther. 9 17 (1998) 2577-2583
17. Maizel Jr. J.V., White D.O., and Scharff M.D. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36 1 (1968) 115-125
18. Kunisawa J., Takahashi I., Okudaira A., Hiroi T., Katayama K., Ariyama T., Tsutsumi Y., Nakagawa S., Kiyono H., and Mayumi T. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen. Eur. J. Immunol. 32 8 (2002) 2347-2355
19. Mackenzie I.C., and Squier C.A. Cytochemical identification of ATPase-positive langerhans cells in EDTA-separated sheets of mouse epidermis. Br. J. Dermatol. 92 5 (1975) 523-533
20. Bergstedt-Lindqvist S., Moon H.B., Persson U., Möller G., Heusser C., and Severinson E. Interleukin 4 instructs uncommitted B lymphocytes to switch to IgG1 and IgE. Eur. J. Immunol. 18 7 (1988) 1073-1077
21. Finkelman F.D., Katona I.M., Mosmann T.R., and Coffman R.L. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140 4 (1988) 1022-1027
22. Edelberg R. Relation of electrical properties of skin to structure and physiologic state. J. Invest. Dermatol. 69 3 (1977) 324-327
23. Alonso A., Meirelles N.C., Yushmanov V.E., and Tabak M. Water increases the fluidity of intercellular membranes of stratum corneum: correlation with water permeability, elastic, and electrical resistance properties. J. Invest. Dermatol. 106 5 (1996) 1058-1063
24. + cells after transcutaneous application on human skin. J. Invest. Dermatol. 126 6 (2006) 1316-1322
25. Jung S., Otberg N., Thiede G., Richter H., Sterry W., Panzner S., and Lademann J. Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J. Invest. Dermatol. 126 8 (2006) 1728-1732
26. Baroli B., Ennas M.G., Loffredo F., Isola M., Pinna R., and López-Quintela M.A. Penetration of metallic nanoparticles in human full-thickness skin. J. Invest. Dermatol. 127 7 (2007) 1701-1712
27. Tada Y., Asahina A., Fujita H., Sugaya M., and Tamaki K. Langerhans cells do not produce interferon-γ. J. Invest. Dermatol. 120 5 (2003) 891-892
28. Fujita H., Asahina A., Sugaya M., Nakamura K., Gao P., Fujiwara H., and Tamaki K. Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells. J. Invest. Dermatol. 124 2 (2005) 343-350
29. Asahina A., and Tamaki K. Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary?. J. Dermatol. Sci. 44 1 (2006) 1-9
30. Mathers A.R., and Larregina A.T. Professional antigen-presenting cells of the skin. Immunol. Res. 36 1-3 (2006) 127-136
31. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., and Seubert P. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 6740 (1999) 173-177
32. Hock C., Konietzko U., Streffer J.R., Tracy J., Signorell A., Müller-Tillmanns B., Lemke U., Henke K., Moritz E., Garcia E., Wollmer M.A., Umbricht D., de Quervain D.J., Hofmann M., Maddalena A., Papassotiropoulos A., and Nitsch R.M. Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38 4 (2003) 547-554
33. Bayer A.J., Bullock R., Jones R.W., Wilkinson D., Paterson K.R., Jenkins L., Millais S.B., and Donoghue S. Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD. Neurology 64 1 (2005) 94-101
34. Nicoll J.A., Wilkinson D., Holmes C., Steart P., Markham H., and Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat. Med. 9 4 (2003) 448-452
35. Monsonego A., Imitola J., Petrovic S., Zota V., Nemirovsky A., Baron R., Fisher Y., Owens T., and Weiner H.L. Aβ-induced meningoencephalitis is IFN-γ-dependent and is associated with T cell-dependent clearance of Aβ in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 103 13 (2006) 5048-5053
36. Nikolic W.V., Bai Y., Obregon D., Hou H., Mori T., Zeng J., Ehrhart J., Shytle R.D., Giunta B., Morgan D., Town T., and Tan J. Transcutaneous β-amyloid immunization reduces cerebral β-amyloid deposits without T cell infiltration and microhemorrhage. Proc. Natl. Acad. Sci. U. S. A. 104 7 (2007) 2507-2512